An experienced hematologist-oncologist and blood and marrow transplant specialist with decades of experience in leadership roles in major universities and NCI designated cancer centers. An NIH-funded nationally recognized physician-scientist with research interests in several areas of cancer including Chimeric Antigen Receptor modified T cells (CAR-T), cancer drug resistance, biology of normal and leukemic hematopoietic stem cells, programmed cell death and cellular signaling.
Chief, Jane Nohl Division of Hematology and Center for the study of Blood Diseases at University of Southern California
Medical Oncology